Discover 503 paid clinical trials in New Orleans, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 503
Active & Responsive
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: New Orleans LA, Houston TX, Memphis TN, Atlanta GA, Dallas TX,
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058013
Phase3, Recruiting
Active & Responsive
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
for
Depressive Disorder, Major
Location: New Orleans LA, Huntsville AL, Atlanta GA, Decatur GA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 64
Code: NCT06785012
Phase2, Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Location: New Orleans LA, Germantown TN, Atlanta GA, Dallas TX,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Active & Responsive
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
for
Mitral Valve Regurgitation
Location: New Orleans LA, Atlanta GA, Dallas TX, Charleston SC,
Sponsor: Annetine Gelijns
Sex: All
Age: 60+
Code: NCT05051033
Recruiting
Active & Responsive
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Active & Responsive
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight